Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marchese

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID VaccinesRaj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, et al.
The Journal of Infection|February 15, 2024
Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccinesRaj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, et al.
The Journal of Infection|June 28, 2025
Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform-specific priming and immune imprintingRaj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, et al.
Vaccine|June 6, 2025
Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19)Germán Áñez, Alice McGarry, Wayne Woo, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID VaccinesRaj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, et al.
The Journal of Infection|February 15, 2024
Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccinesRaj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, et al.
The Journal of Infection|June 28, 2025
Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform-specific priming and immune imprintingRaj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, et al.
Vaccine|June 6, 2025
Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19)Germán Áñez, Alice McGarry, Wayne Woo, et al.
Pageof 8